Pricing Log in Create free account
Friday 6 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue
+21.8%
EPS
−80.6%
Free cash flow
+6.78%

Quarter to September 2026, against a year earlier

45.04 0.50 +1.12%
Market cap
$7.5B
P/E
0.0×
Fwd P/E
−85.9×
Dividend yield
—
F-score
7/9
Altman Z
5.33
Beneish M
−3.29
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Alkermes plc (ALKS) Current ratio

Alert me on Current ratio

Alkermes plc's current ratio at the end of the quarter to 30 September 2026 was 2.4×, down 1.1× from fiscal 2025 (3.5×). Over the past ten years it has ranged from 2.3× (fiscal 2021) to 3.7× (fiscal 2016); the current reading is higher than 91% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.5× 16.68%
FY2024 3.0× 6.55%
FY2023 2.9× 25.74%
FY2022 2.3× 0.76%
FY2021 2.3× (11.09%)
FY2020 2.5× 3.07%
FY2019 2.5× (15.00%)
FY2018 2.9× 4.15%
FY2017 2.8× (25.51%)
FY2016 3.7× 16.69%

Quarterly newest first

Period Current ratio Change
Sep 2026 2.4× 5.42%
Jun 2026 2.3× 1.49%
Mar 2026 2.3× (36.16%)
Dec 2025 3.5× (3.31%)
43 more quarters

Against its own ten years

Low 2.3× High 3.7×
Ten-year median 2.9×
Current reading's percentile 91

Current ratio against peers

Company Current ratio
KNSA Kiniksa Pharmaceuticals International, plc compare 3.9×
LNTH Lantheus Holdings, Inc. compare 3.2×
ALKS Alkermes plc 2.4×
LQDA Liquidia Corporation compare 2.3×
ELAN Elanco Animal Health Incorporated compare 2.1×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.9×
HIMS Hims & Hers Health, Inc. compare 0.9×
SUPN Indivior Pharmaceuticals Inc. compare 0.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on ALKS